The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 25, 2020

Filed:

Jul. 13, 2017
Applicant:

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Keith D. Crawford, Westwood, MA (US);

Christopher Southgate, Sudbury, MA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); C12N 5/0775 (2010.01); A61K 35/12 (2015.01); A61K 35/24 (2015.01); A61K 35/14 (2015.01); C12N 5/0784 (2010.01); C12N 5/0789 (2010.01); C12N 5/077 (2010.01); C12N 5/071 (2010.01);
U.S. Cl.
CPC ...
A61K 35/24 (2013.01); A61K 35/12 (2013.01); A61K 35/14 (2013.01); C12N 5/067 (2013.01); C12N 5/0639 (2013.01); C12N 5/0647 (2013.01); C12N 5/0653 (2013.01); C12N 5/0654 (2013.01); C12N 5/0655 (2013.01); C12N 5/0657 (2013.01); C12N 5/0658 (2013.01); C12N 5/0661 (2013.01); C12N 5/0662 (2013.01); C12N 5/0668 (2013.01); C12N 5/0676 (2013.01); C12N 2500/25 (2013.01); C12N 2500/36 (2013.01); C12N 2500/38 (2013.01); C12N 2501/105 (2013.01); C12N 2501/11 (2013.01); C12N 2501/125 (2013.01); C12N 2501/135 (2013.01); C12N 2501/155 (2013.01); C12N 2501/22 (2013.01); C12N 2501/2303 (2013.01); C12N 2501/235 (2013.01); C12N 2501/2306 (2013.01); C12N 2501/26 (2013.01); C12N 2501/39 (2013.01); C12N 2501/40 (2013.01); C12N 2501/41 (2013.01); C12N 2501/999 (2013.01);
Abstract

The invention provides a quiescent stem cell having the capacity to differentiate into ectoderm, mesoderm and endoderm, and which does not express cell surface markers including MHC class I, MHC class II, CD44, CD45, CD13, CD34, CD49c, CD73, CD105, CD90, CD66A, CD66E, CXCR4, CD133 or an SSEA. The invention further provides a proliferative stem cell, which expresses genes including Oct-4, Nanog, Sox2, GDF3, P16INK4, BMI, Notch, HDAC4, TERT, Rex-1, TWIST, KLF-4 and Stella but does not express cell surface markers including MHC class I, MHC class II, CD44, CD45, CD13, CD34, CD49c, CD73, CD105, CD90, CD66A, CD66E, CXCF4, CD133 or an SSEA. The cells of the invention can be isolated from adult mammals, have embryonic cell characteristics, and can form embryoid bodies. Methods for obtaining the stem cells, as well as methods of treating diseases and differentiating the stem cells, are also provided.


Find Patent Forward Citations

Loading…